Jhonatan
Q. Ossa, Felipe Jaramillo-Ayerbe, Juan Paulo Cardona
Dermatologist,
Internal Medicine profesor, Universidad de Caldas, Manizales, Colombia.
Dermatopathologist,
Chief of Dermatology program, Universidad de Caldas
Clinical
Oncologist, Internal Medicine professor, Universidad de Caldas
*Corresponding
author: Jhonatan Q. Ossa, Dermatologist, Internal
Medicine profesor, Universidad de Caldas, Manizales, Colombia, Email: jhonaqo84@gmail.com
Citation:
Jhonatan
Q. Ossa (2020) Necrobiotic Xanthogranuloma With Non- Progressive Hematological
Dyscrasia, A Case Report. Sci World J Skin Dis Venereol, 1(1); 1-3
Copyright:
© 2020, Jhonatan
QO, et al., This is
an open-access article distributed under the terms of the Creative Commons
Attribution 4.0 International License, which permits unrestricted use,
distribution and reproduction in any medium, provided the original author and
source are credited
ABSTRACT
Necrobiotic
Xanthogranuloma (NXG) is a rare systemic and progressive histiocytosis of
unknownaetiologyin which 80% of the cases is considered a marker of paraproteinemia,
a monoclonal gammopathy IgG sometimes related with Multiple Myeloma (MM), it
has also been associated with other progressive and non-progressive hematologic
dyscrasias. Although its location in the periorbital area is distinctive, its
course can be systemic and generalized. In the beginning, the diagnosis is
difficult and its clinical-pathological correlation becomes necessary. Its
prognosis is generally good, but currently there is no standardized or
effective treatment;surgery is an option yet with high tendency for recurrence.
We present aXNG clinical case associated with autoimmune idiopathic
thrombocytopenia, which has remained stable for more than 15 years, although
previous reports have shown this association more with adult orbital xanthogranulomathan
NXG itself, the clinical significance is yet to be knownaccording to this
spectral, infrequent and enigmatic condition.
KEYWORDS:
Necrobiotic, Xanthogranuloma, Histiocytoses, Periorbital, Thrombocytopenia.